Streetbeat News

Earnings

ALZN

BEEP

CONN

Insiders at Alzamend Neuro, Mobile Infrastructure, and Conn's have recently made significant stock purchases, signaling potential confidence in their companies' futures. Conn's reported a narrower Q4 loss than expected, Mobile Infrastructure is preparing for its Q1 2024 earnings release, and Alzamend Neuro received FDA approval to proceed with a PTSD study.

Portfolio Pulse from Avi Kapoor

April 24, 2024 | 10:54 am

BIIB

Biogen has reaffirmed its 2024 adjusted EPS guidance of $15.00-$16.00, indicating a 5% growth from 2023, aligning with a consensus of $15.48. The company anticipates a low- to mid-single digit percentage decline in total revenue compared to 2023 but expects its core pharmaceutical revenue to remain stable. Additionally, Biogen projects a low-double digit percentage growth in operating income and a mid-single digit percentage improvement in operating margin.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:53 am

AVY

Avery Dennison Corporation has revised its FY24 earnings guidance downwards, adjusting the reported earnings per share (EPS) forecast from $8.65-$9.15 to $8.60-$9.10. However, the company maintains its adjusted EPS outlook of $9.00 to $9.50, excluding an estimated $0.40 per share impact from restructuring charges and other items.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:52 am

BXMT

Blackstone Mortgage Trust reported its Q1 2024 distributable EPS prior to charge-offs at $0.65, surpassing the estimate of $0.43.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:52 am

EVR

Evercore (NYSE:EVR) reported Q1 2024 adjusted EPS of $2.13, surpassing the $2.09 estimate, but its sales of $587.328M fell short of the expected $636.381M. This represents a slight decrease in earnings and a modest increase in sales from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:51 am

LII

Lennox International (LII) has reaffirmed its FY24 revenue guidance, projecting around 7% growth, with 2% attributed to the AES acquisition. Additionally, Lennox has updated its EPS guidance for FY24 from the range of $18.50-$20.00 to a narrower range of $19.00-$20.00, with an estimated average of $19.72.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:49 am

HELE

Helen of Troy has projected its adjusted earnings per share (EPS) for fiscal year 2025 to be in the range of $8.70 to $9.20, which is below the estimated $9.72.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:49 am

BIIB

Biogen (NASDAQ:BIIB) reported Q1 2024 earnings of $3.67 per share, surpassing the $3.44 estimate, marking a 7.94% increase from last year. However, their sales of $2.291B fell short of the $2.311B estimate, a 7.00% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:49 am

HELE

Helen Of Troy has projected its FY25 revenue to be between $1.965B and $2.025B, which is below the estimated $2.04B.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:48 am

AVY

Avery Dennison (NYSE:AVY) reported Q1 adjusted earnings of $2.29 per share, surpassing the $2.15 estimate, marking a 34.71% increase from last year. Sales reached $2.15B, meeting estimates and showing a 4.16% year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:47 am